ZNF85: A Potential Drug Target and Biomarker (G7639)

Target Name: ZNF85

NCBI ID: G7639

ZNF85

ZNF85: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. One of the ZFPs, ZNF85 (also known as zinc finger protein 85 or HTF1), is a protein that has been identified as a potential drug target and biomarker. This protein is of great interest to researchers because of its unique structure and its involvement in various cellular processes.

The ZNF85 protein is a 21-kDa protein that contains 21 zinc fingers. ZNF85 is a member of the ZNF gene family, which is known for the production of zinc fingers, a type of non-coding RNA-binding protein. The ZNF gene family has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the unique features of ZNF85 is its structure. ZNF85 has a highly conserved extracellular domain that is similar to that of other ZFPs. This conserved domain is important for the stability and function of the protein. ZNF85 also has a unique intracellular domain that is characterized by a long amino acid sequence that contains a series of zinc fingers. This zinc finger sequence is similar to that of other ZFPs and is thought to play a role in the protein's stability and function.

The zinc finger sequence in ZNF85 is important for its function in various cellular processes. One of the roles of zinc fingers is to regulate gene expression. ZNF85 has been shown to play a role in the regulation of gene expression in various cell types, including cancer cells. For example, studies have shown that ZNF85 can suppress the expression of genes involved in cell growth, apoptosis, and angiogenesis, which are processes that are critical for the development and progression of cancer.

In addition to its role in gene regulation, ZNF85 is also involved in the regulation of cellular signaling pathways. One of the zinc fingers in ZNF85 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway. This signaling pathway is involved in various cellular processes, including cell growth, differentiation, and survival. ZNF85 has been shown to regulate the activity of the PI3K/Akt signaling pathway by interacting with the protein PIK3R, which is involved in the signaling pathway.

The potential drug target status of ZNF85 is also supported by its involvement in various diseases. ZNF85 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that ZNF85 is involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, ZNF85 has also been shown to be involved in the development of cancer, including breast cancer and colorectal cancer.

The potential biomarker status of ZNF85 is also supported by its expression in various biological samples, including cancer cells, neurodegenerative diseases, and autoimmune diseases. ZNF85 has been shown to be expressed in a variety of biological samples, including cancer cells, neurodegenerative diseases, and autoimmune diseases. This expression suggests that ZNF85 could be used as a biomarker for these diseases and as a potential drug target.

In conclusion, ZNF85 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and involvement in various cellular processes make it an attractive target for research into the mechanisms of disease and the development of new treatments. Further research is needed to fully understand the role of ZNF85 in

Protein Name: Zinc Finger Protein 85

Functions: May be a transcriptional repressor

The "ZNF85 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF85 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets